Corporate Banner
Satellite Banner
Technology Networks Header
Sunday, November 23, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Intelsius Introduces Revised PharmaTherm™ Solutions
Wednesday, January 29, 2014
Company introduces PharmaTherm™ solutions at the 13th Annual Cool Chain Europe Summit in Luxembourg.

Brooks Introduces Next-Generation Automated Sample Storage Systems
Wednesday, January 22, 2014
Feature-rich, flexible, reliable technology in a standardized platform.

Fluxion Biosciences Releases IsoFlux Rare Cell Enrichment Kit
Tuesday, January 21, 2014
New bead chemistry enables more options for targeted cell enrichment.

Promega ViaFect™ Transfection Reagent Delivers High Performance Transfection Across Multiple Cell Lines, Including iPS Cells
Tuesday, January 14, 2014
Novel reagent formulation allows researchers to develop assays in more cell lines of interest

Ready-to-Use Stable Cell Lines
Thursday, January 02, 2014
AMSBIO has expanded its portfolio of stable cell lines. The new cell lines express endogenous or recombinant proteins and are available in a ready-to-use format to facilitate your research efforts.

2D Barcode Scanner for Frozen Samples
Thursday, January 02, 2014
Micronic announce a further addition to its popular ‘blue-white’ Tracxer Code Reader line.

kbiosystems Ltd UK Releases 3 New Products
Thursday, January 02, 2014
products will be launched at the Plant & Animal Genomics (PAG) and SLAS meetings in January 2014, San Diego, CA.

New Cryostat Offers High-Quality, Efficient Frozen Sectioning
Monday, December 23, 2013
Improved ergonomics and functionality improve operator comfort and enhance workflow.

Reinnervate Launches Novel Platform for the Propagation of Stem Cells
Thursday, December 19, 2013
Novel platform for passaging stem cells in 3D using Alvetex®Strata technology.

<< 3 4 5 6 7 8 9 >>
Showing Results 51 - 60 of 489
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv